Brief: Annexon Reports Fourth Quarter And Year-End 2022 Financial Results

Annexon

06/03/2023 12:08

March 6 (Reuters) - Annexon Inc  ANNX.O :
    * ANNEXON REPORTS FOURTH QUARTER AND YEAR-END 2022 FINANCIAL
RESULTS AND REITERATES ANTICIPATED MILESTONES
    * WELL-CAPITALIZED WITH OPERATING RUNWAY INTO 2025
    * INITIAL CLINICAL DATA FROM PHASE 2 TRIAL OF ANX007 IN
PATIENTS
WITH GEOGRAPHIC ATROPHY ON-TRACK FOR MID-2023
    * CASH AND CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS WERE
$242.7
MILLION AS OF DECEMBER 31, 2022
    * QTRLY LOSS PER SHARE $0.48
    * Q4 EARNINGS PER SHARE VIEW $-0.53 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7rl4wx 
Further company coverage:  ANNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))